Poster Spotlight: Thursday, 30th June 2022, 13:00-13:45
Presentations of the chosen abstracts:
ESOP’s yellow hand: are the pharmaceutical laboratories really are devoting all the necessary? (Ferdinand Badibouidi)
Incidence Of Cisplatin-Induced Nephrotoxicity And Associated Risk Factors: Single-Center Experience (Rowaida Reda)
Oral Communications: Saturday, 2nd July 2022, 08:30-10:00
Presentations of the chosen abstracts:
Frequency of measuring body weight in (sub)populations of patients with cancer treated with chemotherapy (Mirjam Crul)
Extended in-use stability of the generic nab-paclitaxel medicine Pazenir® (Robert Terkola)
National Cancer Information System, Ireland – configuring a national drug file and regimen library (Caoimhe O’Leary)
Evolution of clinical trials in onco-hematology in a reference center: does it worth a dedicated structure ? (Anaïs Mordohay)
Effectiveness and safety of durvalumab for advanced non cell lung cancer (Garbiñe Lizeaga Cundin)
Abstracts for Poster Session: Thursday, 30th June – Saturday 2nd July 2022
Table of contents: Please search in this following document for the title you submitted. The same line gives you the information which topic your abstract belongs to and this document includes your abstract.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.